Researchers at DTU have found a way to increase the body’s natural immune response to fight cancer cells, which significantly increases the effectiveness of chemotherapy.
A research team from DTU Health Technology has for many years worked with a drug delivery system to maximize the effectiveness of cancer treatment.
Now they have presented a new liposome system to help with chemo-immunotherapy.
Better treatment response
Cancer cells react with the body’s natural immunological reaction system and essentially prevent it from attacking them and promote its further growth. The newly presented system targets specific cells in the body to increase their ability to destroy cancer cells.
The effectiveness of this treatment along with chemotherapy has shown a remarkable increase in these important immune cells. Their presence is a promising sign of a better response to chemotherapy.
Although no one has yet been cured by the new technology, and chemoimmunology is still in its early stages, it brings hope for a future where immunotherapy can be used to treat cancer patients.
New findings from KU studies may help ban coronavirus infections
A new study conducted by the University of Copenhagen in collaboration with the University of California has revealed a new co-factor involved in the infection process, which can help ban coronavirus infections. The co-factor is called heparan sulfate, which is a polysaccharide used in various biological processes. Simple blood-thinning drug heparin is therefore now a potential candidate for the treatment of coronavirus infections.
Laboratories for radioactivity analysis at DTU awarded ISO certificate
DTU’s world-leading laboratories within radioactivity analysis have just had their ISO certificate renewed. The technology allows testing of alpha and beta particles without the gamma particles that are easier to measure. DTU has perfected this technology for the last 60 years.
DTU proposes a safer camel milk solution
A research project carried out at DTU has created a freeze-dried solution that makes camel milk safer to consume. African farmers do not have the right conditions to store camel milk, which makes the acidification process a breeding ground for microorganisms such as E. coli and salmonella. The newly created compound turns out to kill dangerous microorganisms during lactic acidosis.
Glucagon a warning sign for diabetes study
Researchers at the University of Copenhagen have introduced a new concept in the fight against diabetes: glucagon resistance. It reduces the sensitivity to the blood sugar regulating hormone glucagon. It is often observed in people with fatty liver – a common denominator for diabetes cases.
Novo Nordisk Fund raises millions for new medical research
As much as DKK 108.6 million was transferred from the Novo Nordisk Foundation to the University of Copenhagen to develop a new, innovative tactic for finding a new medicine. Producing drugs that work takes a long time and requires a lot of ‘trial and error’. Quantum computers have an enormous computing power, which will now be used to create, among other things, medical formulas.
More personal approach is needed in the treatment of Parkinson’s
For many years, researchers have been trying to figure out why Parkinson’s patients experience such different symptoms. A study conducted at Aarhus University has shown that Parkinson’s is actually caused by two different diseases with two different origins. It is suggested that in order to achieve better results in the treatment of Parkinson’s patients, a more personal approach should be taken and the medication should be tailored to the patient.
Source: The Nordic Page